A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 31/495 (2006.01) A61K 31/44 (2006.01) A61K 31/445 (2006.01)
Patent
CA 2126571
2126571 9312790 PCTABS00024 6-and/or 2-substituted 1-arylindole derivative of general formula (I), where Ar is optionally substituted phenyl or a hetero aromatic group; X and X' are hydrogen, halogen, alkyl, alkoxy, hydroxy, alkylthio, alkylsulfonyl, alkyl- or dialkylamino, cyano, trifluoromethyl, or trifluoromethylthio; or X and X' are linked to constitute a 5-7 membered carbocyclic ring; R1 is hydrogen, or lower alkyl, provided that when X is hydrogen or fluoro, then R1 is not hydrogen; Y is nitrogen or carbon; R is hydrogen, alkyl, alkenyl, cycloalkyl, or cycloalkylmethyl, or R is a substituent of formula (1a) or (1b), wherein n is 2-6; W is oxygen or sulfur; U is nitrogen or carbon; Z is -(CH2)m-, -CH=CH-, -COCH2-, -CSCH2- or 1,2-phenylene; V is oxygen, sulfur, CH2 or NR2; V1 is -O-R4, -S-R4, -CHR4R5 or -NR4R5; and R3, R4 and R5 are hydrogen, alkyl, alkenyl, cycloalkyl, or cycloalkylmethyl; inhibit the firing of spontaneously active dopamine neurones in the ventral tegmental area of the brain and are thus useful for the treatment of psychoses in humans.
Perregaard Jens Kristian
Skarsfeldt Torben
H. Lundbeck A/s
Robic
LandOfFree
Use of arylindole derivatives for the treatment of psychoses does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Use of arylindole derivatives for the treatment of psychoses, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of arylindole derivatives for the treatment of psychoses will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1859589